Eric J. Gilbert;Michael W. Miller;Jack D. Scott;Andrew W. Stamford;William J. Greenlee;Jay Weinstein
发明人:
Eric J. Gilbert,Michael W. Miller,Jack D. Scott,Andrew W. Stamford,William J. Greenlee,Jay Weinstein
申请号：
US12564678
公开号：
US08236805B2
申请日:
2009.09.22
申请国别(地区):
US
年份:
2012
代理人:
摘要：
Compounds of Formula (I):or pharmaceutically acceptable salts, solvates, or esters thereof, are useful in treating diseases or conditions mediated by CB1 receptors, such as metabolic syndrome and obesity, neuroinflammatory disorders, cognitive disorders and psychosis, addiction (e.g., smoking cessation), gastrointestinal disorders, and cardiovascular conditions.
